EFL
ABBV icon

ERn Financial LLC’s AbbVie ABBV Stock Holding History

ERn Financial LLC’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$404K Buy
1,545
+82
+6% +$21K 0.07% 119
2026
Q2 		$368K Hold
1,463
– – 0.06% 123
2026
Q1 		$318K Sell
1,463
-16
-1% -$3.55K 0.06% 118
2025
Q4 		$338K Sell
1,479
-14
-0.9% -$3.19K 0.06% 116
2025
Q3 		$346K Sell
1,493
-28
-2% -$5.7K 0.07% 111
2025
Q2 		$282K Sell
1,521
-64
-4% -$11.9K 0.06% 124
2025
Q1 		$332K Sell
1,585
-139
-8% -$27K 0.05% 156
2024
Q4 		$306K Buy
1,724
+637
+59% +$117K 0.05% 167
2024
Q3 		$215K Buy
+1,087
New +$203K 0.03% 179
2023
Q3 		– Sell
-1,511
Closed -$204K – 167
2023
Q2 		$204K Buy
1,511
+6
+0.4% +$880 0.04% 165
2023
Q1 		$240K Buy
1,505
+83
+6% +$12.7K 0.05% 159
2022
Q4 		$230K Buy
+1,422
New +$218K 0.05% 163
2022
Q2 		– Sell
-1,643
Closed -$266K – 165
2022
Q1 		$266K Buy
+1,643
New +$239K 0.06% 145

Other funds holding ABBV

State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

ERn Financial LLC's ABBV Position: Q3 2026 in Review

ERn Financial LLC increased its AbbVie (ABBV) stake by 5.6% in Q3 2026, buying an estimated $21K and bringing the position to 1,545 shares worth $404K. The position accounts for 0.07% of the portfolio, ranked #119.

ERn Financial LLC first reported a position in ABBV in Q1 2022 and has held it in 13 quarters since. 3,222 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • ERn Financial LLC held 1,545 shares of AbbVie worth $404K as of Q3 2026.
  • ERn Financial LLC bought 82 AbbVie shares in Q3 2026, an estimated $21K.
  • AbbVie made up 0.07% of ERn Financial LLC's portfolio in Q3 2026, its #119 holding.
  • ERn Financial LLC first reported a position in AbbVie in Q1 2022 and has held it in 13 quarters since.
  • 3,222 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on ERn Financial LLC's 13F filing for Q3 2026, filed 28 Oct 2026.